Manoj Kumar Windlass has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Manoj Kumar Windlass, Promoter of Windlas Biotech, has filed an annual declaration under SEBI's Takeover Regulations confirming that he and persons acting in concert have not created any new encumbrance (pledge, lien, or similar charge) on the company's shares during FY 2024-25, other than what was already disclosed. The filing is made on behalf of the entire Promoter and Promoter Group. Annexure I lists the equity shareholdings of all promoter-group members, totaling 1,30,65,352 shares of face value ₹5 each. The largest holder is the AKW WBL Family Private Trust with 83,81,340 shares, followed by Ashok Kumar Windlass with 44,00,000 shares.
This is a routine annual compliance filing that signals promoter shares remain free of fresh pledging or encumbrances, which is generally seen as a positive indicator of promoter confidence and financial stability. No material change in shareholding or new risk to shareholders is implied.